Oncolytics Biotech Announces New Translational Data From An Ongoing Study Showing Pelareorep’s Ability To Increase HPV-16-Specific T Cell Clones And Tumor-Infiltrating Lymphocyte Clones In Second-Line Or Later Squamous Cell Anal Cancer Patients; Immune...